The Impact of a Twelve-Month Comprehensive Program of Cognitive Training for Alzheimer Patients: A Pilot Study

  1. Rodríguez-Mora, Álvaro
  2. Cordón, José R.
  3. de la Torre, Gabriel G.
  4. Mestre, José M.
  1. 1 Instituto Universitario para el Desarrollo Social y Sostenible, Universidad de Cádiz, Jerez de la Frontera,11406 Cádiz
  2. 2 Department of Psychology, Universidad de Cádiz, Puerto Real, 11519 Cádiz, Spain
  3. 3 Instituto de Investigación e Innovación Biomédica de Cádiz, Universidad de Cádiz, 11009 Cádiz, Spain
Mostrar afiliaciones +
Revista:
Psychiatry International

ISSN: 2673-5318

Año de publicación: 2020

Volumen: 1

Número: 2

Páginas: 83-97

Tipo: Artículo

DOI: 10.3390/PSYCHIATRYINT1020010 GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Psychiatry International

Resumen

Research has shown that non-pharmacological therapies can be useful in the treatment of Alzheimer’s disease (AD), significantly delaying cognitive decay. However, most AD interventions did not last beyond six months. Hence, little is known about the effect of these programs in the AD patients after six months of treatment. The purpose of this study was to evaluate the efficacy of the twelve-month Comprehensive Program of Cognitive Training (CPCT) for a sample of AD patients and to compare the results with the average annual rate of change. Thirty-nine AD patients participated in the study. The CPCT consists of a set of cognitive stimulations, intervention in activities of daily life (ADL), and motor training for 12 months. All patients were evaluated at baseline and in three-month intervals via the Mini Mental State Examination (MMSE), the Cambridge Cognitive Examination (CAMCOG), the Lawton Instrumental Activities of Daily Living Scale (IADL), and the Global Deterioration Scale (GDS). After CPCT implementation, there were no significant differences in the MMSE, IADL, and GDS evaluations between baseline and twelve months. Concerning the CAMCOG evaluation, there was no significant difference between the baseline and sixth-month assessments. Overall, the participants’ cognitive functioning did not decline when compared to the average annual rate of change. The CPCT extends the benefit of non-pharmacological interventions for AD patients to twelve months. Its implementation might provide the patients’ relatives with some guarantee concerning the delay of the disease. Future research may investigate the efficacy of the CPCT in comparison with a control group and over a more extended period. View Full-Text

Referencias bibliográficas

  • 10.1159/000490851
  • 10.1136/bmjopen-2014-005247
  • 10.1017/S1041610212001822
  • 10.1080/13607863.2011.586622
  • 10.1002/gps.2464
  • 10.1586/14737175.8.5.751
  • 10.1002/14651858.CD005562.pub2
  • 10.1080/13607860500409492
  • 10.1080/1360786021000045854
  • 10.1186/1745-6215-14-152
  • 10.1007/s11065-013-9227-4
  • 10.1177/1533317512441386
  • 10.1002/gps.4521
  • 10.1002/gps.2086
  • 10.1097/WAD.0b013e318231e46e
  • 10.1186/1741-7015-9-129
  • 10.1177/070674371105601004
  • 10.1186/alzrt189
  • 10.1111/j.1532-5415.2012.03938.x
  • 10.1159/000316119
  • 10.1192/bjp.bp.114.148130
  • 10.3233/JAD-142364
  • 10.1016/j.arr.2012.07.001
  • 10.1177/1533317512440493
  • 10.1002/gps.5076
  • 10.1186/1471-2377-12-151
  • 10.1097/JGP.0b013e3181c37ce9
  • 10.1590/S1807-59322011000800015
  • 10.1016/0022-3956(75)90026-6
  • 10.1192/bjp.149.6.698
  • 10.1017/S0033291799002068
  • 10.1097/00006199-197005000-00029
  • 10.1176/ajp.139.9.1136
  • 10.1097/00002093-200101000-00001
  • 10.1016/S0211-139X(07)73515-1
  • 10.1002/gps.1168
  • 10.1002/gps.381
  • 10.1111/j.1532-5415.1993.tb06740.x
  • 10.12998/wjcc.v1.i8.233
  • 10.1016/j.archger.2007.01.055
  • 10.1159/000095600
  • 10.1177/0891988718813724